Table 1.
Baseline characteristics of the study participants (n = 100)
| iBGStar (n = 50) | Controls (n = 50) | p value | |
|---|---|---|---|
| Age (years) | 38 ± 11 | 39 ± 12 | 0.79 |
| Diabetes duration (years) | 25 ± 12 | 22 ± 13 | 0.24 |
| Gender (% male) | 48 | 56 | 0.4 |
| BMI (kg/m2) | 27.1 ± 5.1 | 27.3 ± 5.5 | 0.82 |
| A1c (%) | 8.0 ± 0.9 | 7.7 ± 1.0 | 0.15 |
| Number of SMBG measures per day | 4.8 ± 1.1 | 5.2 ± 1.1 | 0.07 |
| Basal insulin dose per day | 31 ± 13 | 27 ± 17 | 0.20 |
| Bolus insulin dose per day | 22 ± 15 | 26 ± 18 | 0.19 |
| Total insulin dose per day | 53 ± 20 | 53 ± 29 | 0.93 |
| Total insulin per day per kg of body weight | 0.7 ± 0.2 | 0.7 ± 0.3 | 0.88 |
| Hypoglycemia fear scale | 59 ± 12 | 58 ± 13 | 0.70 |
| Behavior scale | 24 ± 6 | 23 ± 6 | 0.32 |
| Worry scale | 35 ± 9 | 35 ± 10 | 0.93 |